Senate Committee Report
Underlined text would be added to current law. Struck-through text would be removed.
| By: Hughes | S.B. No. 2429 | |
| (In the Senate - Filed March 13, 2025; March 25, 2025, read | ||
| first time and referred to Committee on State Affairs; | ||
| April 7, 2025, reported adversely, with favorable Committee | ||
| Substitute by the following vote: Yeas 10, Nays 0; April 7, 2025, | ||
| sent to printer.) | ||
| Click here to see the committee vote | ||
| COMMITTEE SUBSTITUTE FOR S.B. No. 2429 | By: Hughes |
| A BILL TO BE ENTITLED | |
| AN ACT | |
| relating to genetic information security for residents of this | |
| state; providing a civil penalty; providing a private cause of | |
| action. | |
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | |
| SECTION 1. Subtitle H, Title 2, Health and Safety Code, is | |
| amended by adding Chapter 174 to read as follows: | |
| CHAPTER 174. SECURITY OF GENETIC INFORMATION | |
| Sec. 174.001. SHORT TITLE. This chapter may be cited as the | |
| Texas Genomic Act of 2025. | |
| Sec. 174.002. DEFINITIONS. In this chapter: | |
| (1) "Company" means a sole proprietorship, | |
| organization, association, corporation, partnership, joint | |
| venture, limited partnership, limited liability partnership, or | |
| limited liability company that exists to make a profit. The term | |
| includes a wholly owned subsidiary, majority-owned subsidiary, | |
| parent company, or affiliate of those entities or business | |
| associations. | |
| (2) "Domicile" means the country in which: | |
| (A) a company or nonprofit organization is | |
| formed, incorporated, or registered and headquartered; | |
| (B) a company's or nonprofit organization's | |
| affairs are primarily conducted; or | |
| (C) the majority of the company's ownership | |
| shares are held. | |
| (3) "Foreign adversary" has the meaning assigned by 15 | |
| C.F.R. Section 791.4(a). | |
| (4) "Genome sequencer" means any device or platform | |
| used to conduct genome sequencing, resequencing, or isolation or | |
| other genome research. | |
| (5) "Genome sequencing" means any method used to | |
| determine the identity and order of nucleotide bases in the human | |
| genome. | |
| (6) "Human genome" means the set of DNA found in human | |
| cells. | |
| (7) "Medical facility" means a facility licensed or | |
| registered by a state or federal agency to provide health care | |
| services that receives any state funding, including pass-through | |
| federal money provided to a state agency for grant awards. | |
| (8) "Software" means computer programs and related | |
| equipment used for genome sequencing or the operation, control, | |
| analysis, research, or other functions of genome sequencers. | |
| Sec. 174.003. APPLICABILITY. This chapter applies to a | |
| medical facility, research facility, company, or nonprofit | |
| organization that conducts research on or testing of genome | |
| sequencing or the human genome in this state. | |
| Sec. 174.004. PURPOSE AND LEGISLATIVE POLICY. (a) The | |
| purpose of this chapter is to ensure that a medical facility, | |
| research facility, company, or nonprofit organization subject to | |
| this chapter and acting on behalf of a foreign adversary does not | |
| gain access to the genetic information of residents of this state. | |
| (b) The policy of this state is to: | |
| (1) oppose the collection and analysis of genomic | |
| information by a foreign adversary or for use by a foreign | |
| adversary; and | |
| (2) support sanctions the United States Department of | |
| Commerce or the United States Department of Defense imposes on a | |
| medical facility, research facility, company, or nonprofit | |
| organization engaged in the collection and analysis of genomic | |
| information for use by a foreign adversary. | |
| Sec. 174.005. PROHIBITED USE OF CERTAIN GENOME SEQUENCERS | |
| AND GENOME SEQUENCING TECHNOLOGIES. A medical facility, research | |
| facility, company, or nonprofit organization subject to this | |
| chapter may not use a genome sequencer or software produced by or on | |
| behalf of: | |
| (1) a foreign adversary; | |
| (2) a state-owned enterprise of a foreign adversary; | |
| (3) a company or nonprofit organization domiciled | |
| within the borders of a country that is a foreign adversary; or | |
| (4) an owned or controlled subsidiary or affiliate of | |
| a company or nonprofit organization domiciled within the borders of | |
| a country that is a foreign adversary. | |
| Sec. 174.006. PROHIBITED SALE OF GENOMIC INFORMATION IN | |
| BANKRUPTCY OR REORGANIZATION. A medical facility, research | |
| facility, company, or nonprofit organization subject to this | |
| chapter may not sell or otherwise transfer genomic sequencing data | |
| of residents of this state as part of a bankruptcy proceeding or | |
| pursuant to a plan of reorganization under Chapter 11 of the United | |
| States Bankruptcy Code (11 U.S.C. Section 1101 et seq.) to: | |
| (1) a foreign adversary; | |
| (2) a state-owned enterprise of a foreign adversary; | |
| (3) a company or nonprofit organization domiciled | |
| within the borders of a country that is a foreign adversary; or | |
| (4) an owned or controlled subsidiary or affiliate of | |
| a company or nonprofit organization domiciled within the borders of | |
| a country that is a foreign adversary. | |
| Sec. 174.007. REQUIREMENTS FOR GENOMIC INFORMATION | |
| STORAGE. (a) A medical facility, research facility, company, or | |
| nonprofit organization subject to this chapter shall store all | |
| genome sequencing data of residents of this state only at a location | |
| in the United States. | |
| (b) A medical facility, research facility, company, or | |
| nonprofit organization subject to this chapter that stores genome | |
| sequencing data of residents of this state, including storage of | |
| genome sequencing data through a contract with a third-party data | |
| storage company, shall ensure the security of the genome sequencing | |
| data using reasonable encryption methods, restriction on access, | |
| and other cybersecurity best practices. | |
| (c) Except as authorized by the attorney general under | |
| Subsection (d), a medical facility, research facility, company, or | |
| nonprofit organization subject to this chapter shall ensure genome | |
| sequencing data of residents of this state, other than open data, is | |
| inaccessible to any person located outside of the United States. | |
| (d) A medical facility, research facility, company, or | |
| nonprofit organization subject to this chapter that stores genome | |
| sequencing data of residents of this state may apply to the attorney | |
| general in the form and manner prescribed by attorney general rule | |
| to allow remote access to genome sequencing data of residents of | |
| this state by persons located outside of the United States. The | |
| attorney general may allow remote access to genome sequencing data | |
| of residents of this state only if the attorney general determines | |
| that: | |
| (1) remote access is necessary for the facility, | |
| company, or organization to perform its functions; | |
| (2) appropriate security safeguards are implemented | |
| for remote access; and | |
| (3) remote access is not available to any person | |
| located within the borders of a country that is a foreign adversary. | |
| Sec. 174.008. REQUIRED ANNUAL CERTIFICATION OF COMPLIANCE. | |
| (a) Not later than December 31 of each year, a medical facility, | |
| research facility, company, or nonprofit organization subject to | |
| this chapter shall certify to the attorney general that the | |
| facility, company, or organization is in compliance with this | |
| chapter. | |
| (b) An attorney representing a medical facility, research | |
| facility, company, or nonprofit organization subject to this | |
| chapter shall submit the certification required under Subsection | |
| (a). | |
| Sec. 174.009. INVESTIGATIVE AUTHORITY OF ATTORNEY GENERAL. | |
| (a) The attorney general may investigate an allegation of a | |
| violation of this chapter. | |
| (b) Any person may notify the attorney general of a | |
| violation or potential violation of this chapter. | |
| Sec. 174.010. CIVIL PENALTY. (a) A medical facility, | |
| research facility, company, or nonprofit organization that | |
| violates this chapter is liable to this state for a civil penalty of | |
| $10,000 for each violation. | |
| (b) The attorney general may bring an action to recover the | |
| civil penalty imposed under this section. | |
| (c) An action under this section may be brought in a | |
| district court in: | |
| (1) Travis County; or | |
| (2) a county in which any part of the violation occurs. | |
| (d) The attorney general shall deposit a civil penalty | |
| collected under this section in the state treasury to the credit of | |
| the general revenue fund. | |
| (e) The attorney general may recover reasonable expenses | |
| incurred in obtaining a civil penalty under this section, including | |
| court costs, reasonable attorney's fees, investigative costs, | |
| witness fees, and deposition expenses. | |
| Sec. 174.011. PRIVATE CAUSE OF ACTION. (a) A resident of | |
| this state who is a patient or research subject of a medical | |
| facility, research facility, company, or nonprofit organization | |
| subject to this chapter and who is harmed by the storage or use of | |
| the patient's or subject's genome sequencing data in violation of | |
| this chapter may bring an action against the facility, company, or | |
| organization that violated this chapter and is entitled to obtain: | |
| (1) the greater of: | |
| (A) actual damages; or | |
| (B) statutory damages in an amount not to exceed | |
| $5,000 for each violation; and | |
| (2) court costs and reasonable attorney's fees. | |
| (b) Sections 41.003 and 41.004, Civil Practice and Remedies | |
| Code, do not apply to an action brought under this section. | |
| SECTION 2. (a) Except as provided by Subsection (b) of this | |
| section, the change in law made by this Act applies only to a cause | |
| of action that accrues on or after the effective date of this Act. A | |
| cause of action that accrues before the effective date of this Act | |
| is governed by the law in effect on the date the cause of action | |
| accrued, and the former law is continued in effect for that purpose. | |
| (b) Section 174.006, Health and Safety Code, as added by | |
| this Act, applies only to a bankruptcy filing that occurs on or | |
| after the effective date of this Act. | |
| SECTION 3. This Act takes effect September 1, 2025. | |
| * * * * * |
Official text from the Texas Legislature. Formatting has been adapted for reading on Ratifi.